 SOUTH SAN FRANCISCO, Calif., May 05, 2021 GLOBE NEWSWIRE -- Today Annexon, Inc. Annexon Nasdaq: ANNX, a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, announced that Douglas Love, Esq., President Chief Executive Officer, will present at the Bank of America Securities 2021 Virtual Healthcare Conference on May 12, 2021 at 11:45 am EDT. 